Healthcare provider profile · identity verified

Jay Frederick Sullivan, MD

Family Practice · PULASKI, NY · NPI 1861426413

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	312	79
Levothyroxine Sodium	Levothyroxine Sodium	311	67
Atorvastatin Calcium	Atorvastatin Calcium	261	64
Pantoprazole Sodium	Pantoprazole Sodium	220	54
Potassium Chloride	Potassium Chloride	182	44
Losartan Potassium	Losartan Potassium	179	40
Metoprolol Succinate	Metoprolol Succinate	172	47
Pravastatin Sodium	Pravastatin Sodium	144	37
Tamsulosin Hcl	Tamsulosin Hcl	142	25
Jardiance	Empagliflozin	139	32
Eliquis	Apixaban	134	27
Furosemide	Furosemide	134	35
Torsemide	Torsemide	129	34
Gabapentin	Gabapentin	126	33
Spironolactone	Spironolactone	123	28
Lisinopril	Lisinopril	118	35
Ozempic	Semaglutide	118	19
Famotidine	Famotidine	113	31
Alprazolam	Alprazolam	110	22
Azithromycin	Azithromycin	104	66
Amlodipine Besylate	Amlodipine Besylate	100	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	98	24
Omeprazole	Omeprazole	94	31
Xarelto	Rivaroxaban	88	18
Clopidogrel	Clopidogrel Bisulfate	78	21
Ramipril	Ramipril	78	22
Carvedilol	Carvedilol	75	19
Sertraline Hcl	Sertraline Hcl	75	17
Janumet Xr	Sitagliptin Phos/Metformin Hcl	74	16
Metformin Hcl Er	Metformin Hcl	73	20
Doxycycline Hyclate	Doxycycline Hyclate	71	42
Venlafaxine Hcl Er	Venlafaxine Hcl	69	14
Allopurinol	Allopurinol	67	16
Januvia	Sitagliptin Phosphate	66	16
Azelastine Hcl	Azelastine Hcl	64	22
Duloxetine Hcl	Duloxetine Hcl	62	17
Hydrochlorothiazide	Hydrochlorothiazide	60	15
Methylprednisolone	Methylprednisolone	60	37
Fluoxetine Hcl	Fluoxetine Hcl	58	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	58	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	58	12
Irbesartan	Irbesartan	57	15
Metoprolol Tartrate	Metoprolol Tartrate	56	12
Mupirocin	Mupirocin	54	29
Prednisone	Prednisone	54	14
Ezetimibe	Ezetimibe	52	13
Meloxicam	Meloxicam	50	14
Alendronate Sodium	Alendronate Sodium	49	suppressed
Colchicine	Colchicine	47	11
Breo Ellipta	Fluticasone/Vilanterol	45	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Celecoxib	Celecoxib	43	suppressed
Cilostazol	Cilostazol	43	11
Esomeprazole Magnesium	Esomeprazole Magnesium	43	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	suppressed
Anastrozole	Anastrozole	41	11
Synjardy	Empagliflozin/Metformin Hcl	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Bupropion Hcl Sr	Bupropion Hcl	38	suppressed
Cephalexin	Cephalexin	37	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Glimepiride	Glimepiride	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	11
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Clonazepam	Clonazepam	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Amoxicillin	Amoxicillin	30	18
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Tresiba Flextouch U-200	Insulin Degludec	30	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	12
Amiloride Hcl	Amiloride Hcl	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	16
Colesevelam Hcl	Colesevelam Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Repatha Sureclick	Evolocumab	27	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Eszopiclone	Eszopiclone	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	13
Klor-Con M10	Potassium Chloride	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Donepezil Hcl	Donepezil Hcl	22	suppressed
Nateglinide	Nateglinide	22	suppressed
Topiramate	Topiramate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Carbamazepine	Carbamazepine	21	suppressed
Np Thyroid	Thyroid,pork	21	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	12
Fluconazole	Fluconazole	20	15
Novolog Flexpen	Insulin Aspart	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	18	18
Bupropion Xl	Bupropion Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Lagevrio (Eua)	Molnupiravir	17	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Modafinil	Modafinil	15	suppressed
Ramelteon	Ramelteon	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Naproxen	Naproxen	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Felbamate	Felbamate	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Baclofen	Baclofen	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Finasteride	Finasteride	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error